Endocrinology. Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro— results of a prospective, randomized in-vitro fertilization study

By Dor J.   Bider D.   Shulman A.   Levron J.   Shine S.   Mashiach S.  

Human Reproduction, Vol. 15, Iss. 6, 2000-06 ,pp. : 1225-1230

Oxford University Press

Access to resources Recommend Favorite

Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.

By Valbuena D   Pellicer A   Guanes P P   Remohí J   Simón C  

Human Reproduction, Vol. 12, Iss. 10, 1997-10 ,pp. : 2118-2122

Oxford University Press

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Pregnancy. Human chorionic gonadotrophin concentrations in early pregnancy after in-vitro fertilization

By Bjercke Sverre  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1642-1646

Oxford University Press

Access to resources Recommend Favorite

In-vivo and in-vitro assessment of the influence of ritodrine and oxytocin on the placental secretion of human chorionic gonadotrophin and placental lactogen

By Meuris Sylvain  

Human Reproduction, Vol. 11, Iss. 3, 1996-03 ,pp. : 664-667

Oxford University Press

Access to resources Recommend Favorite